$1055.37
26.862.61%
al cierre: Sep 2, 5:00 PM EST
$1055.37
N/A
After hour: 4:00 PM EST
argenx SE
ARGXNASDAQ
Fusiones y adquisiciones: Forte Biosciences (FBRX) was acquired by argenx (ARGX) on Thursday, August 27, 2026
argenx Earnings & Forecasts
argenx (ARGX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
argenx Guidance
argenx (ARGX) publicó su última previsión de enero 12, 2026 para fiscal year 2025. La compañía estimó ingresos en un rango de $4.15B - $4.15B para el período.
En comparación con la previsión anterior, argenx elevado redujo su previsión de ingresos desde un rango anterior de $1.29B - $1.29B.
argenx ha emitido 4 actualizaciones de orientación entre el enero 8, 2024 y el enero 12, 2026. During this period, the company raised its outlook 3 times, reflecting management's growing confidence in business performance.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $5.56 | $4.39 | $5.64 | $3.88 |
| Actual | $7.32 | $5.52 | $8.02 | $5.18 |
| Surprise | +31.6% | +25.7% | +42.2% | +33.5% |
| Revenue | ||||
| Estimate | $1.29B | $1.16B | $1.18B | $978.0M |
| Actual | $1.54B | $1.31B | $1.32B | $1.15B |
| Surprise | +19.6% | +13.6% | +11.8% | +17.7% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $7.53 | $8.23 | $8.03 | $9.06 |
| Revenue | ||||
| Consensus | $1.64B | $1.76B | — | — |